March 4, 2013 - Atlanta, GA. The U.S. Women and PrEP Working Group, a coalition of more than 50 women from leading AIDS and women’s health organizations, today called on US government agencies to coordinate a national agenda that will quickly and accurately answer questions about how the antiretroviral (ARV) drug Truvada can best be made available as an HIV prevention option for women at risk of HIV infection. Continue Reading...
Do you get our newsletter?
Sign up for our monthly Newsletter and get the latest info in you in box.
What is HIV? Get basic information on HIV, how it is different from AIDS, and getting tested for HIV – what tests, where to get them, and more.
Learn all about HIV testing: why, when, and where to get tested; types of tests – including at-home tests, and getting your results.